M Naoi


Affiliation: Gifu International Institute of Biotechnology
Country: Japan


  1. request reprint
    Naoi M, Maruyama W. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders. Curr Pharm Des. 2010;16:2799-817 pubmed
  2. Naoi M, Maruyama W, Yi H, Inaba K, Akao Y, Shamoto Nagai M. Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm (Vienna). 2009;116:1371-81 pubmed publisher
    ..This review discusses the new role of mitochondria in regulation of neuronal cell death of neurodegenerative disorders. ..
  3. Naoi M, Maruyama W. Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. Expert Rev Neurother. 2009;9:1233-50 pubmed publisher
    ..This review presents recent advances in our understanding of the neuroprotection offered by MAOB-Is and possible evaluation of neuroprotective efficacy in clinical samples is discussed. ..